ONCHOCERCIASIS
Clinical trials for ONCHOCERCIASIS explained in plain language.
Never miss a new study
Get alerted when new ONCHOCERCIASIS trials appear
Sign up with your email to follow new studies for ONCHOCERCIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug moxidectin put to the test against river blindness in massive safety trial
Disease control CompletedThis large Phase 3 trial compared the safety of a single dose of moxidectin versus ivermectin in nearly 13,000 people living in areas where river blindness is common. Some participants also received albendazole for lymphatic filariasis. The goal was to see if moxidectin causes fe…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
River blindness drug trial aims to find right dose for kids
Disease control CompletedThis study tested a single dose of moxidectin in 36 children aged 4 to 17 who have or are at risk of onchocerciasis (river blindness). The goal was to find a dose for children 4-11 years that works like the standard 8 mg dose used in older kids and adults. Researchers measured dr…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE1 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 26, 2026 13:56 UTC